Great Valley Advisor Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.51M Buy
45,768
+579
+1% +$66.8K 0.1% 181
2025
Q4
$4.76M Sell
45,189
-1,828
-4% -$172K 0.09% 199
2025
Q3
$3.95M Sell
47,017
-51,947
-52% -$4.28M 0.08% 214
2025
Q2
$7.83M Sell
98,964
-5,160
-5% -$410K 0.17% 129
2025
Q1
$9.35M Sell
104,124
-4,651
-4% -$434K 0.2% 119
2024
Q4
$10.8M Buy
108,775
+6,112
+6% +$630K 0.24% 100
2024
Q3
$11.7M Buy
102,663
+7,064
+7% +$839K 0.29% 90
2024
Q2
$11.8M Buy
95,599
+5,885
+7% +$758K 0.33% 80
2024
Q1
$11.8M Sell
89,714
-9,337
-9% -$1.15M 0.36% 71
2023
Q4
$10.8M Buy
99,051
+5,982
+6% +$621K 0.38% 66
2023
Q3
$9.58M Buy
93,069
+9,052
+11% +$976K 0.4% 67
2023
Q2
$9.69M Buy
84,017
+2,499
+3% +$284K 0.41% 63
2023
Q1
$8.67M Buy
81,518
+5,292
+7% +$571K 0.4% 64
2022
Q4
$8.46M Buy
76,226
+24,931
+49% +$2.55M 0.43% 56
2022
Q3
$4.42M Sell
51,295
-1,372
-3% -$122K 0.25% 101
2022
Q2
$4.8M Buy
52,667
+6,745
+15% +$598K 0.26% 94
2022
Q1
$3.64M Sell
45,922
-476
-1% -$37.5K 0.21% 123
2021
Q4
$3.52M Sell
46,398
-293
-0.6% -$23.3K 0.22% 119
2021
Q3
$3.51M Sell
46,691
-1,293
-3% -$98.3K 0.24% 113
2021
Q2
$3.72M Sell
47,984
-2,631
-5% -$196K 0.27% 98
2021
Q1
$3.72M Sell
50,615
-8,921
-15% -$658K 0.36% 62
2020
Q4
$4.65M Buy
59,536
+2,956
+5% +$226K 0.48% 44
2020
Q3
$4.48M Sell
56,580
-1,492
-3% -$117K 0.55% 39
2020
Q2
$4.29M Buy
58,072
+11,149
+24% +$839K 0.7% 31
2020
Q1
$3.44M Buy
46,923
+4,284
+10% +$337K 0.91% 24
2019
Q4
$3.7M Sell
42,639
-2,354
-5% -$193K 0.82% 23
2019
Q3
$3.61M Buy
44,993
+516
+1% +$41.4K 0.87% 19
2019
Q2
$3.55M Buy
44,477
+18,937
+74% +$1.45M 0.89% 19
2019
Q1
$2.03M Buy
25,540
+6,483
+34% +$485K 0.64% 36
2018
Q4
$1.39M Buy
+19,057
New +$1.35M 0.52% 48

Other funds holding MRK

Great Valley Advisor Group's MRK Position: Q1 2026 in Review

Great Valley Advisor Group increased its Merck (MRK) stake by 1.3% in Q1 2026, buying an estimated $66.8K and bringing the position to 45,768 shares worth $5.51M. The position accounts for 0.1% of the portfolio, ranked #181.

Great Valley Advisor Group first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $11.8M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Great Valley Advisor Group held 45,768 shares of Merck worth $5.51M as of Q1 2026.
  • Great Valley Advisor Group bought 579 Merck shares in Q1 2026, an estimated $66.8K.
  • Merck made up 0.1% of Great Valley Advisor Group's portfolio in Q1 2026, its #181 holding.
  • Great Valley Advisor Group first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Great Valley Advisor Group's Merck position peaked at $11.8M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.